Abstract
Use of dietary supplements, especially among athletes is increasing. Among the amino acids, the branched-chain amino acids (BCAA-leucine, valine and isoleucine) are popular as dietary supplements especially among strength training athletes. In particular, leucine as a supplement is widely consumed because it has been implicated to be the key amino acid involved in stimulating muscle protein synthesis. This chapter will present current dietary leucine intakes, define the concept of safe upper limits (UL) and summarize a recent study in humans conducted to address leucine tolerability. In the 2005 Dietary References Intake (DRI) report, men 51 through 70 years of age had the highest intakes, at the 99th percentile for leucine, at 14,100 mg·d-1 (~ 201 mg·kg·d-1). In order to directly explore leucine tolerability in humans we proposed a novel model. We hypothesized that with increasing intakes of leucine above the estimated average requirement (EAR of 50 mg·kg-1·d-1) in adult men, the oxidation of leucine will increase and will reach a maximum, after which the leucine oxidation will achieve a plateau. This ‘metabolic limit’ to oxidize leucine may be used as a marker of an intake after which increasing intakes may result in increasing risk of adverse effects. Five healthy young men participated in the study. Each subject participated in a dose-escalation study design, where graded stepwise increases in leucine intake (150, 250, 500, 750, 1000 and 1250 mg·kg-1·d-1 corresponding to the EAR, EARx3, x5, x10, x15, x20 and x25) were provided on each study day. Oxidation of L-[1-13C]leucine to 13CO2 in breath (F13CO2) was measured on each study day. With increasing intakes of leucine, a dose-response in leucine oxidative capacity was observed, with a breakpoint estimated at 550 mg·kg-1·d-1 or 39 g·d-1. Simultaneous and significant increases in blood ammonia concentrations, plasma leucine concentrations and urinary leucine excretion were observed with leucine intakes higher than 500 mg·kg-1·d-1. These results taken together with the recent animal data suggest that under acute dietary conditions, as a cautious estimate, intakes greater than 500 mg leucine·kg-1·d-1 may potentially increase the risk of adverse events, and could be proposed as the UL for leucine in healthy adults.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Maughan RJ, Depiesse F, Geyer H, International Association of Athletics Federations. The use of dietary supplements by athletes. J Sports Sci. 2007;25:S103–13.
Lun V, Erdman KA, Fung TS, et al. Dietary supplementation practices in Canadian high-performance athletes. Int J Sport Nutr Exerc Metab. 2012;22:31–7.
Braun H, Koehler K, Geyer H, et al. Dietary supplement use among elite young German athletes. Int J Sport Nutr Exerc Metab. 2009;19:97–109.
Young VR. Introduction to the 2nd amino acid assessment workshop. J Nutr. 2003;133:2015S–20.
Buse MG, Reid SS. Leucine. A possible regulator of protein turnover in muscle. J Clin Invest. 1975;56:1250–61.
Anthony JC, Yoshizawa F, Anthony TG, et al. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr. 2000;130:2413–9.
Crozier SJ, Kimball SR, Emmert SW, et al. Oral leucine administration stimulates protein synthesis in rat skeletal muscle. J Nutr. 2005;135:376–82.
Nair KS, Short KR. Hormonal and signaling role of branched-chain amino acids. J Nutr. 2005;135:1547S–52.
Pitkänen HT, Oja SS, Rusko H, et al. Leucine supplementation does not enhance acute strength or running performance but affects serum amino acid concentration. Amino Acids. 2003;25:85–94.
Mero A. Leucine supplementation and intensive training. Sports Med. 1999;27:347–58.
Crowe MJ, Weatherson JN, Bowden BF. Effects of dietary leucine supplementation on exercise performance. Eur J Appl Physiol. 2006;97:664–72.
Coburn JW, Housh DJ, Housh TJ, et al. Effects of leucine and whey protein supplementation during eight weeks of unilateral resistance training. J Strength Cond Res. 2006;20:284–91.
Shimomura Y, Inaguma A, Watanabe S, et al. Branched-chain amino acid supplementation before squat exercise and delayed-onset muscle soreness. Int J Sport Nutr Exerc Metab. 2010;20:236–44.
Walker TB, Smith J, Herrera M, et al. The influence of 8 weeks of whey-protein and leucine supplementation on physical and cognitive performance. Int J Sport Nutr Exerc Metab. 2010;20:409–17.
Thomson JS, Ali A, Rowlands DS. Leucine-protein supplemented recovery feeding enhances subsequent cycling performance in well-trained men. Appl Physiol Nutr Metab. 2011;36:242–53.
Ispoglou T, King RF, Polman RC, et al. Daily L-leucine supplementation in novice trainees during a 12-week weight training program. Int J Sports Physiol Perform. 2011;6:38–50.
Verhoeven S, Vanschoonbeek K, Verdijk LB, et al. Long-term leucine supplementation does not increase muscle mass or strength in healthy elderly men. Am J Clin Nutr. 2009;89:1468–75.
Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes: Energy, Carbohydrate, Fiber, fat, Fatty Acids, Cholesterol, Protein and Amino Acids. Washington, DC: The National Academy Press; 2005.
Millward DJ. Knowledge gained from studies of leucine consumption in animals and humans. J Nutr. 2012;142:2212S–9.
Fernstrom JD. Branched-chain amino acids and brain function. J Nutr. 2005;135:1539S–46.
Matthews DE. Observations of branched-chain amino acid administration in humans. J Nutr. 2005;135:1580S–4.
Pencharz PB, Elango R, Ball RO. An approach to defining the upper safe limits of amino acid intake. J Nutr. 2008;138:1996S–2002.
House JD, Pencharz PB, Ball RO. Phenylalanine requirements determined by using L-[1-14C]phenylalanine in neonatal piglets receiving total parenteral nutrition supplemented with tyrosine. Am J Clin Nutr. 1997;65:984–93.
Sakai R, Miura M, Amao M, et al. Potential approaches to the assessment of amino acid adequacy in rats: a progress report. J Nutr. 2004;134:1651S–5.
Tsubuku S, Hatayama K, Katsumata T, et al. Thirteen-week oral toxicity study of branched-chain amino acids in rats. Int J Toxicol. 2004;23:119–26.
Mawatari K, Katsumata T, Uematsu M, et al. Prolonged oral treatment with an essential amino acid L-leucine does not affect female reproductive function and embryo-fetal development in rats. Food Chem Toxicol. 2004;42:1505–11.
Imamura W, Yoshimura R, Takai M, et al. Adverse effects of excessive leucine intake depend on dietary protein intake: a transcriptomic analysis to identify useful biomarkers. J Nutr Sci Vitaminol (Tokyo). 2013;59:45–55.
Baker DH. Tolerance for branched-chain amino acids in experimental animals and humans. J Nutr. 2005;135:1585S–90.
Elango R, Chapman K, Rafii M, et al. Determination of the tolerable upper intake level of leucine in acute dietary studies in young men. Am J Clin Nutr. 2012;96:759–67.
Riazi R, Wykes LJ, Ball RO, et al. The total branched-chain amino acid requirement in young healthy adult men determined by indicator amino acid oxidation by use of L-[1-13C]phenylalanine. J Nutr. 2003;133:1383–9.
Littell R, Milliken G, Stroup W, Wolfinger R. SAS System for Mixed Models. Cary, NC: SAS Institute; 1996.
Seber GAF. Linear regression analysis. Wiley: New York, NY; 1977.
Pencharz PB, Elango R, Ball RO. Determination of the tolerable upper intake level of leucine in adult men. J Nutr. 2012;142:2220S–4.
Nair KS, Matthews DE, Welle SL, et al. Effect of leucine on amino acid and glucose metabolism in humans. Metabolism. 1992;41:643–8.
Kalogeropoulou D, Lafave L, Schweim K, et al. Leucine, when ingested with glucose, synergistically stimulates insulin secretion and lowers blood glucose. Metabolism. 2008;57:1747–52.
Harper AE, Miller RH, Block KP. Branched-chain amino acid metabolism. Annu Rev Nutr. 1984;4:409–54.
Block KP, Harper AE. Valine metabolism in vivo: effects of high dietary levels of leucine and isoleucine. Metabolism. 1984;33:559–66.
Eriksson S, Hagenfeldt L, Wahren J. A comparison of the effects of intravenous infusion of individual branched-chain amino acids on blood amino acid levels in man. Clin Sci (Lond). 1981;60:95–100.
Hambraeus L, Bilmazes C, Dippel C, et al. Regulatory role of dietary leucine on plasma branched-chain amino acid levels in young men. J Nutr. 1976;106:230–40.
Aftring RP, Block KP, Buse MG. Leucine and isoleucine activate skeletal muscle branched-chain alpha-keto acid dehydrogenase in vivo. Am J Physiol. 1986;250:E599–604.
Stanley CA. Regulation of glutamate metabolism and insulin secretion by glutamate dehydrogenase in hypoglycemic children. Am J Clin Nutr. 2009;90:862S–6.
Erecińska M, Nelson D. Activation of glutamate dehydrogenase by leucine and its nonmetabolizable analogue in rat brain synaptosomes. J Neurochem. 1990;54:1335–43.
Coude FX, Sweetman L, Nyhan WL. Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. J Clin Invest. 1979;64:1544–51.
Phillips SM. Protein requirements and supplementation in strength sports. Nutrition. 2004;20:689–95.
Gleeson M. Interrelationship between physical activity and branched-chain amino acids. J Nutr. 2005;135:1591S–5.
Balage M, Dardevet D. Long-term effects of leucine supplementation on body composition. Curr Opin Clin Nutr Metab Care. 2010;13:265–70.
Cynober L, Bier DM, Kadowaki M, et al. A proposal for an upper limit of leucine safe intake in healthy adults. J Nutr. 2012;142:2249S–50.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Elango, R., Ball, R.O., Pencharz, P.B. (2015). Tolerability of Leucine in Humans. In: Rajendram, R., Preedy, V., Patel, V. (eds) Branched Chain Amino Acids in Clinical Nutrition. Nutrition and Health. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1914-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1914-7_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1913-0
Online ISBN: 978-1-4939-1914-7
eBook Packages: MedicineMedicine (R0)